Bayesian Adaptive Design for Immunotherapy and Targeted Therapy
(Sprache: Englisch)
This book provides a comprehensive review of novel adaptive trial designs for targeted therapies and immunotherapies. This book covers a wide range of novel statistical designs for various clinical settings, including early phase dose-escalation study,...
Jetzt vorbestellen
versandkostenfrei
Buch (Gebunden)
Fr. 165.50
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „Bayesian Adaptive Design for Immunotherapy and Targeted Therapy “
Klappentext zu „Bayesian Adaptive Design for Immunotherapy and Targeted Therapy “
This book provides a comprehensive review of novel adaptive trial designs for targeted therapies and immunotherapies. This book covers a wide range of novel statistical designs for various clinical settings, including early phase dose-escalation study, proof-of-concept trials, and confirmatory studies with registrational. The book includes real-life examples and software to facilitate practitioners to learn and use the designs in practice.
Inhaltsverzeichnis zu „Bayesian Adaptive Design for Immunotherapy and Targeted Therapy “
Introduction to Adaptive Design and Delayed Outcomes.- Basics of Bayesian Statistics.- Phase I Dose-finding Design.- Phase II Design for Interim Monitoring.- Phase I-II Dose-finding Design.- Drug Combination Trial Design.- Conclusion.
Bibliographische Angaben
- Autoren: Haitao Pan , Ying Yuan
- 2023, 2023, XI, 262 Seiten, 50 farbige Abbildungen, Masse: 15,5 x 23,5 cm, Gebunden, Englisch
- Verlag: Springer, Berlin
- ISBN-10: 9811981744
- ISBN-13: 9789811981746
Sprache:
Englisch
Kommentar zu "Bayesian Adaptive Design for Immunotherapy and Targeted Therapy"
0 Gebrauchte Artikel zu „Bayesian Adaptive Design for Immunotherapy and Targeted Therapy“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Bayesian Adaptive Design for Immunotherapy and Targeted Therapy".
Kommentar verfassen